The Importance of Early Investment in Patient Engagement

Patients' real-life experiences and needs are increasingly being incorporated into the design of clinical trials to strengthen drug development programs and inform regulatory guidance, while also helping healthcare providers and care partners recognize current gaps in care. Elevating the voice of the patient (VoP) and providing more patient-centric care is not a new concept, but patient engagement approaches are continually evolving. These collective VoP perspectives ultimately can help enhance clinical trial participation, create more positive patient experiences and improve the overall sustainability of clinical research. This white paper discusses the implementation of a unique early engagement delivery model to help identify patient populations, create more robust clinical trial protocols and develop a new standard for how trials are designed and conducted.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/whitepapers/Importance-Early-Investment-Patient-Engagement-WPCDS041.pdf